Johnson & Johnson Stock News

3M(MMM) jumped nearly 5% in Friday''s trading, bouncing off its lowest levels in 21 months, perhaps helped by a court ruling that upheld Johnson Johnson''s request to use the…

Johnson & Johnson can use the bankruptcy system to resolve multibillion-dollar litigation claiming its talc products cause cancer, a U.S. judge ruled on Friday, signing off on a legal maneuver that enables the company to avoid fighting more than 38,000 individual lawsuits.

The Dow Jones rallied as Vladimir Putin tightened his grip on Ukraine. Etsy stock soared on earnings, as did Block. Johnson & Johnson surged.

News about the conflict in Eastern Europe was contradictory as the trading week came to a close, but markets surged as Wall Street grasped for good news. On Friday, Russian troops reportedly were closing in on the Ukrainian capital of Kyiv. Yet on the same day, the Kremlin said Russian President Vladimir Putin had agreed to send a delegation to the Belarusian capital of Minsk to negotiate with Ukraine. SEE MORE The 22 Best Stocks to Buy for 2022 Chinese President Xi Jinping reportedly also gave a nod toward a peaceful resolution, saying "China supports Russia and Ukraine to resolve issues through negotiations" after a conversation with Putin, according to state-owned CCTV. But some of Friday''s bullishness might also have come from changing expectations for Federal Reserve action this year. "Wall Street anticipates central bank reluctance to go overly aggressive with tightening monetary policy, so they could provide a cushion for a growth hit that will stem the Russia-Ukraine developments," says Edward Moya, senior market strategist at currency data provider OANDA.

Johnson & Johnson (NYSE: JNJ ) shares are trading higher Friday after the company agreed to finalize a proposed $26 billion settlement resolving more than 3,000 lawsuits, mainly by state and local governments, seeking to hold it and three other companies responsible for the opioid abuse crisis. The other companies are distributors McKesson Corp (NYSE: MCK ), AmerisourceBergen Corp (NYSE: ABC ) and Cardinal Health Inc (NYSE: CAH ). Johnson & Johnson was up 4.97% at $166 Friday afternoon at publication. See Also: Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits Johnson & Johnson Daily Chart Analysis The stock recently bounced off support in a sideways channel and has been pushing higher, now nearing the resistance level of the channel. Support was found near … Full story available on Benzinga.com

Then-Ald. Patrick Daley Thompson attends a Chicago City Council meeting at City Hall, Wednesday, June 23, 2021. | Ashlee Rezin/Sun-Times Today’s update is a 5-minute read that will brief you on the day’s biggest stories. Good afternoon. Here’s the latest news you need to know in Chicago. It’s about a 5-minute read that will brief you on today’s biggest stories. This afternoon will be mostly cloudy with a chance of flurries and a high near 29 degrees. Tonight will also be mostly cloudy with a chance of flurries and a low around 16. Tomorrow will be sunny with a high near 35. Sunday will also be sunny with a high near 36 degrees. Top story Desperate for loans, Patrick Daley Thompson put hundreds of thousands in campaign cash in crooked Bridgeport bank Disgraced former Ald. Patrick Daley Thompson has lost his Chicago City Council seat and could go to prison over his dealings with a crooked bank in the Bridgeport neighborhood he represented. But his ties to Washington Federal Bank for Savings go beyond the evidence presented to the jury that found him guilty Feb. 14 of cheating on his income taxes and lying to federal banking regulators.

The settlement of roughly $25 billion was first announced last summer, but was given final approval by the companies after a threshold number of state and local governments agreed to participate.

A ruling on Johnson & Johnson talc litigation is helping shares of the consumer-goods giant, and shares of 3M, which also has a litigation overhang.

The shares of all 30 components of the Dow Jones Industrial Average gained ground in afternoon trading Friday, as the blue chip barometer surged toward its biggest gain in 21 months. Of the Dow''s best percentage performers, shares of both Johnson & Johnson and 3M Co. shot up 5.5%. 3M''s stock is now on track to snap a 10-session losing streak, which is its longest losing streak in 10 years. UnitedHealth Group Inc.''s stock was biggest price gainer, and therefore provided the biggest point boost for the Dow. The health insurer''s stock rose $18.97, or 4.2%, to add about 125 points to the Dow''s price. The weakest perform was Walt Disney Co.''s stock , which rose just 0.1%. The Dow ran up 844 points, or 2.5%, as it headed for the biggest point gain since it soared 912 points on May 18, 2020. The Dow has now bounced 1,795 points, or 5.6%, off Thursday''s intraday low of 32,272.64. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Johnson & Johnson agreed to a $26 billion joint settlement Friday to thousands of claims by state and local governments over the alleged roles it and three other companies played in the opioid pandemic.

Several former scientists and staff from companies like Johnson & Johnson (NYSE: JNJ ), GlaxoSmithKline (NYSE: GSK ) and Schiff Nutrition are bringing a new delivery platform to market that boosts the bioavailability of hemp cannabidiol or CBD . According to the company, NextEvo, its SmartSorb technology not only turns oil-based CBD ingredients into water-soluble ingredients but also enables a higher load of active CBD ingredients. “SmartSorb turns premium, hemp-derived CBD, which is usually oil-soluble, into a water-soluble–like (water-dispersible) emulsion and delivers the equivalent of four times the amount of CBD in oil-based formulations,” … Full story available on Benzinga.com

Drugmaker Johnson & Johnson and three major distributors finalized nationwide settlements over their role in the opioid addiction crisis Friday, an announcement that clears the way for $26 billion to flow to nearly every state and local government in the U.S. Taken together, the settlements are the largest to date among the many opioid-related cases that have been playing out across the country. They''re expected to provide a significant boost to efforts aimed at reversing the crisis in places that have been devastated by it, including many parts of rural America. Johnson & Johnson, AmerisourceBergen, Cardinal Health and McKesson announced the settlement plan last year, but the deal was contingent on getting participation from a critical mass of state and local governments. Friday was the deadline for the companies to announce whether they felt enough governments had committed to participate in the settlement and relinquish the right to sue. The four companies notified lawyers for the governments in the case that their thresholds were met, meaning money could start flowing to communities by April. "We''re never going to have enough money to immediately cure this problem," said Joe Rice, one of the lead lawyers who represented local governments in the litigation that led to the settlement. "What we''re trying to do is give a lot of small communities a chance to try to change some of their problems." While none of the settlement money will go directly to victims of opioid addiction or their survivors, the vast majority of it is required to be used to deal with the epidemic.

Drugmaker Johnson & Johnson and three major distributors finalized nationwide settlements over their role in the opioid addiction crisis on Friday, an announcement that clears the way for $26 billion US to flow to nearly every state and local government in the U.S.

A bankruptcy court judge has upheld Johnson & Johnson''s (JNJ) request to use a bankruptcy strategy to handle 38K lawsuits related to its talc products pending against the company.

Pharmaceutical manufacturer Johnson & Johnson, and major drug distributors announced Friday, they will collectively move forward with a $26 billion settlement in lawsuits filed against them over the opioid crisis.